tetradecanoylphorbol acetate has been researched along with nsc 4347 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, LC; Shen, CC; Shen, YC; Tsai, TH | 1 |
| Bae, JS; Kim, JA; Ku, SK | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and nsc 4347
| Article | Year |
|---|---|
Anti-inflammatory neolignans from Piper kadsura.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Inhibitory Concentration 50; Lignans; Neutrophils; Piper; Plants, Medicinal; Reactive Oxygen Species; Taiwan; Tetradecanoylphorbol Acetate | 2006 |
Piperlonguminine downregulates endothelial protein C receptor shedding in vitro and in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Anti-Inflammatory Agents; Antigens, CD; Cells, Cultured; Dioxolanes; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Protein C Receptor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fruit; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phytotherapy; Piper; Plant Extracts; Plants, Medicinal; Receptors, Cell Surface; Sepsis; Tetradecanoylphorbol Acetate; Time Factors; Tumor Necrosis Factor-alpha | 2014 |